The company has nearly completed prototypes for its first product, Trigger Tome, which is designed for treatment of stenosing tenosynovitis, or trigger finger. The device is used during an outpatient procedure, which saves time and healthcare dollars.
The company plans to begin domestic commercialization of Trigger Tome over the next few months, and a second proprietary product is under development.
Related Articles on Orthopedic Device Companies:
InHealth Media Names Dr. Joseph Purita to Board of Directors
Stryker Buys Extremities Device Company Memometal Technologies for $162M
ORTHOCON Receives FDA 510(k) Clearance for HEMOSORB Apply
